Global Molecular Diagnostics Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024

Industry : Healthcare Date : March 7th, 2019
Tutorials Get 15% Discount on First Report

The global molecular diagnostics market was valued at USD 7.5 billion in 2017, and is likely to generate a demand of USD 15.6 billion by 2024, at a CAGR of 11% over the forecast period. The growth in the market is attributed to the growing number of infectious diseases and chronic diseases across the globe, improving reimbursement scenario, and increasing adoption of advanced diagnostic techniques. Moreover, growing increase in collaborative diagnostic programs, and increasing investments in diagnostic healthcare is further propelling the industry growth. The years used for the assessment are as follows:

Historical year: 2014, 2015 and 2016

Base year: 2017

Forecast period: 2018 – 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year Impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the total global molecular diagnostics market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global molecular diagnostics market
  • Finalizing the overall size and share of the global molecular diagnostics market

OBJECTIVES:

  • To analyze market trends, opportunities, drivers, and restraints associated with the global molecular diagnostics market
  • To study market response with respect to the mergers and acquisitions in the industry
  • To profile key companies operating in the global molecular diagnostics market and provide their competitive landscape

MARKET SCOPE

The research scope for global molecular diagnostics market is as follows:

Product and Service

  • Instruments
  • Reagents and Kits
  • Services and Software

Technology

  • DNA Sequencing and Next-Generation Sequencing (NGS)
  • DNA Microarray
  • Fluorescent in Situ Hybridization
  • Nucleic Acid Amplification (NAT)
  • Polymerase Chain Reaction (PCR)
  • Other

Application

  • Infectious Disease
    • Virology
      • HIV viral load
      • HCV viral load
      • HBV viral load
      • CMV viral load
      • HPV
      • HSV
      • EBV
      • influenza A/B
      • others
    • Bacteriology
      • Chlamydia
      • Gonorrhea
      • pertussis
      • Methicillin-resistant Staphylococcus aureus (MRSA)
      • CT/NG
      • Healthcare Acquired Infections (HAIs)
    • Genomics Testing
      • Inherited Disorders
      • Human Leukocyte Antigen(HLA) testing
      • Pharmacogenetics
    • Blood Donor Screening
    • Oncology
      • Colorectal cancer
      • Pancreatic cancer
      • Brain cancer
      • Kidney cancer
      • Thyroid cancer
      • Breast cancer
      • Lung cancer
      • Melanoma
      • Prostate cancer
      • Precancer
      • Leukemia
      • Lymphoma
      • Bladder cancer
      • Cervical cancer
      • Chest cancer

End-user

  • Laboratories
  • Hospitals
  • Other

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Central & South America
  • Middle East and Africa (MEA)

Molecular diagnostics play an important role in understanding the pathogenesis of various diseases, as well as in their diagnosis and treatment. The healthcare system is critically and crucially dependent upon diagnostics. Molecular diagnostics has transformed diagnosis dynamically by providing insights in the treatment of various diseases.  Molecular diagnostics market represents a relatively new era in medicine that offers benefits of detecting diseases at early stage. The major factors driving the growth are increasing incidences of chronic diseases, and ongoing fight against cancer and other illnesses.

Geographically, North America held the largest share of the market in 2017. The growth in the region is attributed to the increasing elderly population, rising incidence of chronic diseases, and growing development in pharmacogenomics. Moreover, growing demand for infectious disease testing and presence of major player in the region is further boosting the market growth. Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to growing investment in the healthcare diagnostics, and increasing adoption of molecular diagnostics test.

Some of the key companies operating in the market includeQIAGEN , HTG Molecular Diagnostics, Inc., Abbott Laboratories , bioMérieux SA, Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd), Becton, Dickinson and Company, Hologic Inc., Cepheid, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., and Genetic Signatures Ltd among others.molecular diagnostics market

TABLE OF CONTENTS

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope & assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Molecular Diagnostics- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the global molecular diagnostics market

3.4. Value chain analysis

3.5. Market opportunities & trends

3.5.1. Increasing investments in diagnostic healthcare

3.5.2. Growing research and development activities in molecular testing

3.6. Market driver analysis

3.6.1. Increase in collaborative diagnostic programs

3.6.2. Growing demand for genetic and genomic information

3.6.3. Increasing adoption of advanced diagnostic techniques

3.6.4. Improving reimbursement scenario

3.7. Market restraint analysis

3.7.1. High cost of molecular diagnostic tests

3.7.2. Stringent regulatory norms associated with molecular diagnostic test

CHAPTER 4. Competitive Outlook

4.1. Competitive analysis

4.1.1. Industry Analysis-Porters five forces analysis

4.1.2. Company Share Analysis

4.2. Competitive factors

CHAPTER 5. Global Molecular Diagnostics Market Size and Forecast (2014 – 2024)

5.1. Global Molecular Diagnostics Market, By Product and Service

5.1.1. Instruments

5.1.2. Reagents and Kits

5.1.3. Services and Software

5.2. Global Molecular Diagnostics Market, By Technology

5.2.1. DNA Sequencing & Next-Generation Sequencing (NGS)

5.2.2. DNA Microarray

5.2.3. Fluorescent in Situ Hybridization

5.2.4. Nucleic Acid Amplification (NAT)

5.2.5. Polymerase Chain Reaction (PCR)

5.2.6. Other

5.3. Global Molecular Diagnostics Market, By Application

5.3.1. Infectious Disease

5.3.1.1. Virology

   5.3.1.1.1. HIV viral load

   5.3.1.1.2. HCV viral load

   5.3.1.1.3. HBV viral load

   5.3.1.1.4. CMV viral load

   5.3.1.1.5. HPV

   5.3.1.1.6. HSV

  5.3.1.1.7. EBV

  5.3.1.1.8. Influenza A/B

  5.3.1.1.9. Others

   5.3.1.2. Bacteriology

 5.3.1.2.1. Chlamydia

5.3.1.2.2. Gonorrhea

5.3.1.2.3. B. pertussis

5.3.1.2.4. Methicillin-resistant Staphylococcus aureus (MRSA)

5.3.1.2.5. CT/NG

5.3.1.2.6. Healthcare Acquired Infections (HAIs)

5.3.2. Genomics Testing

  5.3.2.1. Inherited Disorders

  5.3.2.2. Human Leukocyte Antigen(HLA) testing

  5.3.2.3. Pharmacogenetics

5.3.3. Oncology

  5.3.3.1. Colorectal cancer

  5.3.3.2. Pancreatic cancer

  5.3.3.3. Brain cancer

  5.3.3.4. Kidney cancer

  5.3.3.5. Thyroid cancer

  5.3.3.6. Breast cancer

  5.3.3.7. Lung cancer

  5.3.3.8. Melanoma

  5.3.3.9. Prostate cancer

  5.3.3.10. Precancer

  5.3.3.11. Leukemia

  5.3.3.12. Lymphoma

  5.3.3.13. Bladder cancer

  5.3.3.14. Cervical cancer

  5.3.3.15. Chest cancer

5.3.4. Blood Donor Screening

5.4. Global Molecular Diagnostics Market, By End-user

5.4.1. Laboratories

5.4.2. Hospitals

5.4.3. Other

CHAPTER 6. Global Molecular Diagnostics Market, By Geography

6.1. North America Molecular Diagnostics Market

6.1.1. North America Molecular Diagnostics Market, By Product and Service (USD Billion)

6.1.2. North America Molecular Diagnostics Market, By Technology (USD Billion)

6.1.3. North America Molecular Diagnostics Market, By Application (USD Billion)

6.1.4. North America Molecular Diagnostics Market, By End-user (USD Billion)

6.1.5. North America Molecular Diagnostics Market, By Country

  6.1.5.1. U.S.

  6.1.5.2. Canada

  6.1.5.3. Mexico

6.2. Europe Molecular Diagnostics Market

6.2.1. Europe Molecular Diagnostics Market, By Product and Service (USD Billion)

6.2.2. Europe Molecular Diagnostics Market, By Technology (USD Billion)

6.2.3. Europe Molecular Diagnostics Market, By Application (USD Billion)

6.2.4. Europe Molecular Diagnostics Market, By End-user (USD Billion)

6.2.5. Europe Molecular Diagnostics Market, By Country

  6.2.5.1. Spain

  6.2.5.2. UK

  6.2.5.3. Netherlands

  6.2.5.4. Germany

  6.2.5.5. Italy

  6.2.5.6. Spain

  6.2.5.7. France

  6.2.5.8. Rest of Europe

6.3. Asia-Pacific Molecular Diagnostics Market

6.3.1. Asia-Pacific Molecular Diagnostics Market, By Product and Service (USD Billion)

6.3.2. Asia-Pacific Molecular Diagnostics Market, By Technology (USD Billion)

6.3.3. Asia-Pacific Molecular Diagnostics Market, By Application (USD Billion)

6.3.4. Asia-Pacific Molecular Diagnostics Market, By End-user (USD Billion)

6.3.5. Asia-Pacific Molecular Diagnostics Market, By Country

  6.3.5.1. China

  6.3.5.2. Australia

  6.3.5.3. Japan

  6.3.5.4. Singapore

  6.3.5.5. South Korea

  6.3.5.6. India

  6.3.5.7. Rest of Asia-Pacific

6.4. Centeral and South America Molecular Diagnostics Market

6.4.1. Centeral and South America Molecular Diagnostics Market, By Product and Service (USD Billion)

6.4.2. Centeral and South America Molecular Diagnostics Market, By Technology (USD Billion)

6.4.3. Centeral and South America Molecular Diagnostics Market, By Application (USD Billion)

6.4.4. Centeral and South America Molecular Diagnostics Market, By End-user (USD Billion)

6.4.5. Centeral and South America Molecular Diagnostics Market, By Country

  6.4.5.1. Brazil

  6.4.5.2. Rest of Central and South America

6.5. Middle East and Africa Molecular Diagnostics Market

6.5.1. Middle East and Africa Molecular Diagnostics Market, By Product and Service (USD Billion)

6.5.2. Middle East and Africa Molecular Diagnostics Market, By Technology (USD Billion)

6.5.3. Middle East and Africa Molecular Diagnostics Market, By Application (USD Billion)

6.5.4. Middle East and Africa Molecular Diagnostics Market, By End-user (USD Billion)

6.5.5. Middle East and Africa Molecular Diagnostics Market, By Country

  6.5.5.1. South Africa

  6.5.5.2. Saudi Arabia

  6.5.5.3. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. QIAGEN

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. HTG Molecular Diagnostics, Inc.

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. Abbott Laboratories

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. bioMérieux SA

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd)

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. Becton, Dickinson and Company

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. Hologic Inc.

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. Cepheid

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. Siemens Healthcare GmbH

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. Thermo Fisher Scientific Inc.

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

7.11. Genetic Signatures Ltd

7.11.1. Business Overview

7.11.2. Product and Service Offering

7.11.3. Financial Overview

7.11.4. Strategic Developments

Global Molecular Diagnostics Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation and Forecast 2024